![]() |
市场调查报告书
商品编码
1696250
全球 Omega-3 市场 - 2025 至 2032 年Global Omega-3 Market - 2025-2032 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024 年全球 Omega-3 市场规模达到 26.4 亿美元,预计到 2032 年将达到 48.5 亿美元,在 2025-2032 年预测期内的复合年增长率为 7.92%。
市场扩张是由于人类饮食中越来越多地使用 omega-3 成分来增强大脑和心臟健康。此外,预计医疗保健和个人健康方面的消费者支出增加将推动产品需求。随着消费者寻求传统鱼油的替代品,市场不断实现产品来源多样化。磷虾油是最广泛使用的 Omega-3 来源之一,因为与普通鱼油相比,它具有更优良的品质。
此外,Aker Biomarine Antarctic AS 等重要企业正致力于透过引进新的捕捞船来增加其产品供应,以提高产能,该公司 2021 年的收入就是明证。发展中国家的政府正在推出多项措施来鼓励南极磷虾捕捞,包括提供研究资金和组成创新联盟,这可能会刺激产业成长。预计这些变数将在预测期内推动产品需求。
动态的
Omega-3 的健康益处日益增加
人类饮食中需要含有 Omega-3 脂肪酸,尤其是 EPA 和 DHA,以确保适当的生长、发育和健康。它们有益于心臟健康、关节和发炎缓解、眼睛健康、认知功能、怀孕和儿童发育以及免疫功能。众所周知,Omega-3 脂肪酸可以降低心血管疾病的风险。近年来,全球心血管疾病死亡率呈上升趋势。在西撒哈拉以南非洲和南亚,心血管疾病发生率上升。根据联合国人口基金会(印度)的数据,到 2050 年,印度老年人罹患心臟病的数量预计将达到 1,910 万人。
印度和中国等国家心臟病发病率不断上升,对心臟保健产品的需求不断增加,从而促进了 omega-3 产品市场的发展。 Omega-3 脂肪酸还可以帮助预防和治疗多种眼部问题,包括干眼症。根据研究,摄取 omega-3 脂肪酸(无论是透过膳食或补充剂)都可能降低黄斑部病变和青光眼的几率。因此,预计 omega-3 对人类健康不同方面的益处将推动其市场需求。
供应链约束和永续性挑战
全球 Omega-3 市场的主要限制因素之一是由于过度捕捞和环境法规导致的鱼油原料稀缺。大部分 omega-3 产品来自海洋资源,包括鳀鱼、沙丁鱼和鲭鱼,这些资源受季节变化、地缘政治限制和永续性需求的影响。
例如,2023年,全球最大的凤尾鱼油生产国秘鲁因鱼类数量减少而实施捕捞禁令,导致 Omega-3 市场供应短缺和价格不稳定。因此,製造商现在正在寻找替代来源,例如藻类衍生的 omega-3,儘管这些来源仍然更昂贵且需要更高的可扩展性才能满足不断增长的全球需求。
Global Omega-3 Market reached US$ 2.64 billion in 2024 and is expected to reach US$ 4.85 billion by 2032, growing with a CAGR of 7.92% during the forecast period 2025-2032.
The market expansion is due to the increasing use of omega-3 ingredients in the human diet to enhance brain and heart health. Furthermore, rising consumer spending in healthcare and personal well-being is predicted to drive product demand. The market is constantly diversifying its product sources as consumers seek alternatives to traditional fish oil. Krill oil is one of the most extensively used sources of omega-3 because of its superior qualities when compared to regular fish oil.
Furthermore, significant enterprises like as Aker Biomarine Antarctic AS are working on boosting capacity by introducing new catching vessels to increase their product offerings, as evidenced by the company's revenues in 2021. Governments in developing countries are launching a number of initiatives to encourage Antarctic Krill fishing, including providing research money and forming innovative alliances, which could spur industry growth. Such variables are expected to drive the product demand during the forecast period.
Dynamic
Rising Health Benefits of Omega-3
Omega-3s, notably EPA and DHA, are required in the human diet for appropriate growth, development and health. They are beneficial for heart health, joint and inflammation relief, eye health, cognitive function, pregnancy and child development and immune function. Omega-3 fatty acids are recognized to lessen the risk of cardiovascular disease. Cardiovascular disease mortality has recently been on the rise around the world. In Western Sub-Saharan Africa and South Asia, cardiovascular disease rates have risen. According to the United Nations Population Fund (India), the number of instances of heart disease among older adults in India is anticipated to be 19.1 million by 2050.
Countries such as India and China, where the prevalence of heart disease is expanding, create demand for heart health goods, bolstering the omega-3 product market. Omega-3 fatty acids can also help prevent and treat several eye problems, including dry eye syndrome. According to studies, ingesting omega-3 fatty acids, whether in meals or supplements, may lower your chance of getting macular degeneration and glaucoma. As a result, omega-3's benefits in different aspects of human health are projected to boost its market demand.
Supply Chain Constraints and Sustainability Challenges
One of the primary constraints in the global omega-3 market is the scarcity of fish oil-based raw materials due to overfishing issues and environmental regulations. The majority of omega-3 production comes from marine sources including anchovies, sardines and mackerel, which are subject to seasonal changes, geopolitical constraints and sustainability demands.
For example, in 2023, Peru, the world's top producer of anchovy-based fish oil, implemented fishing prohibitions owing to diminishing fish populations, resulting in supply shortages and price instability in the omega-3 market. As a result, manufacturers are now searching for alternate sources like algae-derived omega-3, although these are still more expensive and require more scalability to satisfy expanding worldwide demand.
The global omega-3 market is segmented based on source, type, application and region.
DHA in the global market is expected to drive the market.
In 2024, the DHA segment accounted for the largest percentage of global omega-3 market. The segment's growth is due to the increasing use of the product in newborn formulae to improve an infant's overall health. DHA is the most vital and plentiful omega-3 fatty acid in the human diet, contributing to overall body health. DHA is essential for the development and maturation of an infant's brain and vision.
Furthermore, it is commonly utilized in dietary supplements and fortified foods. It is used to treat dementia, ADHD, CAD and type 2 diabetes. Companies create new items to fulfill market demand. For example, in 2022 orlo Nutrition launched a DHA Starter Kit with an algal omega-3 supplement to assist the brain, heart, joints and body systems.
Growing Health Consciousness in Asia-Pacific.
Asia-Pacific is expected to be the fastest growing region in the global omega-3 market. Several reasons fueling the region's growth include expanding consumer health consciousness, an aging population valuing cognitive health and high birth rates, which increase demand for infant nutritional products. Additionally, the popularity of plant-based diets has resulted in an increase in demand for algae-based omega-3 supplements.
Furthermore, other significant players have innovated, such as Daewoong Bio, which developed CRA-TG in June 2024, a combination of the hyperlipidemia medicine rosuvastatin and omega-3 intended at lowering patients' triglyceride levels. This new addition to Daewoong Bio's hyperlipidemia treatment range joins nine other medications, including Atorvastatin Tablets and Oma-TG Soft Capsule. CRA-TG has exhibited better lipid profiles and increased tolerance and stability.
The major global players in the market include Polaris, Koninklijke DSM N.V., BASF SE, Corbion NV, ADM, Simris Alg AB, Croda International Plc, Novotech Nutraceuticals, Inc., Source Omega LLC and Algarithm.
Target Audience 2024
LIST NOT EXHAUSTIVE